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Summary.-The effect of preheating EMT6 cells in vitro on their response to cyto-
toxic agents at either 43°C or 37°C has been investigated. Preheating for 3 h at 40°C
produced measurable protection (thermal tolerance) to subsequent treatment for
1 h at 43°C. This preheat treatment was further found to reduce cell killing by BLM
and BCNU (drug tolerance) present during 1 h at 43°C. In contrast, no such heat-
induced drug tolerance was seen with ADR. An additional effect with ADR was the
apparent elimination ofheat-induced thermal tolerance at toxic drug doses. However,
preheating under these conditions had no effect on the subsequent cytotoxicity of any
of these drugs at 37°C. Also, preheating for 1 h at 43°C was found to sensitize cells to
BLM and BCNU toxicity at 37°C but to protect against ADR toxicity.
The results are discussed in relation to known mechanisms of cell killing by heat
and of thermal tolerance.
HYPERTHERMIA has been shown to
potentiate the action of some cytotoxic
drugs (reviewed by Hahn (1978) and by
Field & Bleehen (1979)). The recent
demonstration of the phenomenon of
thermal tolerance (Gerner et al., 1976) led
us to investigate the influence of thermal
tolerance on sensitivity to 3 cytotoxic
drugs.
Gerner et al. showed that by returning
HeLa cells to 37°C after an initial thermal
dose at 44°C their sensitivity to subse-
quent hyperthermic treatments is re-
duced. Direct evidence of the develop-
ment of thermal tolerance during con-
tinuous exposure to hyperthermia (42-50C)
has been described by Harisiadis et al.
(1977) for CHO cells. Prolonged exposure
at 42 5°C was also found to give consider-
able protection from subsequent exposure
to acute hyperthermia at 45°C.
Preheating cells has also been shown to
affect their reponse to cytotoxic agents.
Hahn & Strande (1976) have shown the
development of heat-induced resistance to
adriamycin (ADR). CHO cells preheated
* To wvhom correspon(lence should be addlressed.
for varying times at 43°C became pro-
gressively more resistant to subsequent
ADR treatment at 43°C. However, over
the times and drug concentrations used,
preheat at 41°C did not appear to confer
ADR resistance on the cells. Heat-induced
resistance to actinomycin D has also been
reported for CHO cells (Donaldson et al.,
1978). Exposures to 43°C with actino-
mycin D for more than 30 min, or preheat-
ing at 43TC before drug exposure, both
reduced the cytotoxicity ofactinomycin D.
In this study, the effect of preheating
EMT6 cells in vitro on their subsequent
response to cytotoxic agents at either
43°C or 37°C has been investigated.
MATERIALS AND METHODS
Cells. Full details of the EMT6/M/CC line
have been given elsewhere (Twentyman &
Bleehen, 1975). Cells were grown and treated
in 60ml glass medical flat bottles. Exponenti-
ally growing cultures in Eagle's medium
supplemented with 2000 newborn calf serum
were used 2 days after inoculation of 2 x 105
cells into the bottles in 5 ml of medium.
Flasks wAere gassed writh 50o Co2 in air.THERMAL TOLERANCE AND DRUG CYTOTOXICITY
Some cells tended to float off from the
monolayer during heat treatment. It was
necessary to collect these for inclusion in the
assay of cell survival, and the trypsinisation
procedure was modified to permit this.
Medium was transferred to a 30ml plastic
universal container, the bottle was rinsed
twice with 2-5 ml 0-1% trypsin, each rinsing
being added to the medium in the universal.
The combined medium and washings were
centrifuged at 1000 rev/min (170 g) for 5 min
while the bottle was incubated at 37°C for
15 min. The detached cells from the bottle
were then resuspended in 1-5 ml growth
medium and added to the pellet of collected
floating cells. The cells were then counted
using a haemocytometer and the cell-survival
assay was continued as has been previously
described.
Drugs.-The drugs used in this study were:
(1) 1.3 Bis- (2- chloroethyl - 1 -nitrosourea)
(BCNU) kindly supplied by the Drug
Development Branch, Developmental Thera-
peutics Program, Division of Cancer Treat-
ment, National Cancer Institute (Bethesda,
Md) in 100mg vials. This was dissolved in
3 ml absolute alcohol and then further diluted
as required in Hanks' balanced salt solution
(HBSS) immediately before use in all cases.
(2) Bleomycin (BLM, Lundbeck) obtained
as a freeze-dried 15mg plug. This was dis-
solved in HBSS, diluted to 2500 [kg/ml and
stored at -20'C in small aliquots. Each
aliquot was thawed at 37°C and further
diluted with HBSS before use.
(3) Adriamycin (ADR: doxorubicin HCI,
Pharmitalia) obtained as 10 mg freeze-dried
powder with lactose. This was dissolved in
HBSS, diluted to 250 ,ug/ml and stored at
-20°C in small aliquots. Each was thawed at
37°C and further diluted with HBSS before
use. All drugs were added to bottles in 0-2 ml
IBSS.
Treatment details.-All heat treatments
were effected by total immersion of the
bottles in a circulating water bath with the
temperature controlled to +01°C (Grant
Ltd., U.K.). Measurements wNithin the flasks
showed that the bottles equilibrated to the
waterbath temperature within 5 min of
immersion. All 37°C treatments were carried
out in a 37°C incubator. All periods ofpreheat
were carried out in the absence of any added
drug. After the preheat treatment, drug was
introduced before transferring bottles to
either 43°C or 37'C for 1 h. Trypsinisation
was performed immediately after this drug
treatment.
Each experiment included replicate deter-
minations of surviving fractions and all
experiments 'were repeated at least once.
Statistical analysis. The results -were
analysed on the following basis: let the sur-
viving fraction for preheated cells in an
individual experiment at drug dose j be pi;
let the corresponding determination for non-
preheated cells be qj. Let j=0 define the zero-
dose determinations. Under the assumption
that the same proportional increase in sur-
viving fraction for preheated cells occurs as
at zero dose of the drug, the expected sur-
viving fraction for preheated cells at dosej is
poqj/qo. Thus, the ratio of observed to ex-
pected surviving fractions is
Pj/PO
qjlqo
These values are expressed as a percentage
in the results section.
The statistical method examines the differ-
ence between observed and expected sur-
viving fractions on a logarithmic scale viz:
(logpj- logpo) -(log qj-log qo). The method
averages this difference over experiments and
divides it by its standard error. The result has
approximately a t-distribution under the
Null Hypothesis and can be compared with
tables of the distribution to obtain the
probability (P) level. The values of P are
showun in the text. The method of calculation
of the appropriate standard error and degrees
of freedom is available from the authors on
request.
It is not thought helpful to showN, standard-
error bars, as these wiould reflect interexperi-
mental variations whereas the measurement
pi/Po
qjlqo
is calculated for each experiment and ave-
raged over experiments, thus eliminating
interexperiment variation.
RESULTS
Fig. 1 shows the time-course over 4 h of
the development of heat-induced thermal
tolerance of cells preheated at 40°C and
subsequently exposed to 43°C for 1 h.
Tolerance has attained its maximum by
3 h of preheating at 40°C. Similar time-
courses and degrees of thermal tolerance
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Fi(c. 1. The effect on the survival of EMT6
cells of preheat exposures for 0-4 h at 40°C
immediately before a 1 h exposure to 43TC.
were observed at preheat temperatures of
39TC, 41°C and 42°C. There was no
evidence, however, for the induction of
tolerance to subsequent exposure for 1 h
at 430C for periods of up to 16 h preheat
treatment at 38TC.
Thermal tolerance and drug cytotoxicity
at elevated temperatures
When a lh exposure to 43°C, in the
presence of a range of doses of either
BCNU or BLM, was preceded by a 3h
treatment at 40°C, heat-induced drug
tolerance was seen (Figs 2a and b).
Statistical analysis shows that for
BCNU, at drug levels of 4-10 tg/ml,the
observed cell survival for preheated cells
was greater than expected (see Statistical
Analysis) for non-preheated cells with
P<001. For BLM, the difference was
significant at all drug levels measured,
with P<0-01.
Under the same preheat conditions,
however, for a lh exposure to 43°C plus
ADR theresultis concentrationdependent,
and amounts to an apparent progressive
loss of thermal tolerance, but no heat-
induced drug tolerance is found (Fig. 3).
The statistical analysis of these data
shows that at all drug concentrations
greater than 0'01 ig/ml, the observed cell
survival for preheated cells was less than
the expected cell survival for non-pre-
heated cells, P<0 01.
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FI. 2. The effect of a 3 h pretreatment at
40°C on the subsequent response of EMIT6
cells to BCNU (a) and BLAI (b) at 43°C for
I h. * 1 h at 43°C*;A 3 h at 40°C+ 1h at
430C*; A Calculated expected SF for 3 h
at 40°C+ 1 h at 43°C.
* Mean of several replicate experiments.
The Table summarizes the data for the
3 drugs and shows the ratio of the ob-
served surviving fraction for preheated
TABLE. The ratio of the observed surviving
fraction for preheated cells to that expected
following drug treatment, expressed as a
percentage at varying concentrations of
BLM, BCNU and ADR
Drug
BCNU
BLAI
ADR
Concentration
( tg/ml)
2
4
6
8
10
2
10
20
0*01
0 033
0-1
0-33
1
.3.3
Pj_ x 100
poqj/qo
119
304
815
4,520
4,790
149
151
314
356
21-2
16-2
18 6
16
2-5
10-33
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FIG. 3.-The effect of a 3h pretreatment at
400C on the subsequent response of EMT6
cells to ADR at 430C for 1 h. * 1 h at 430C*;
A 3 h at 400C+ I h at 4300*; A Calculated
expected SF for 3 h at 40°C + 1 h at 4300.
* Mean of several replicate experiments.
cells to that expected, expressed as a per-
centage. From the Table it can be seen
that for BCNU and BLM this ratio in-
creases with increasing drug concentration
but decreases for ADR.
The time-course and temperature de-
pendence of pretreatment which leads to
this effect have been studied:
(a) Fig. 4 shows the effect of increasing
times of preheat exposure at 4000 before
1 h treatment at 4300 with either 0-1 or
1.0 ,g/ml ADR. This demonstrates that
0.1 ,ug/ml ADR has very little influence on
the development of heat-induced thermal
tolerance, whereas 1.0 ,ug/ml at 43T0 after
preheating appears to eliminate the ther-
mal tolerance, i.e. the surviving fraction
remains constant whether or not the cells
are preheated. Similar results were ob-
tained over this preheating time-course
for preheat temperatures of390C and 410C.
(b) The results for temperature depend-
ence are summarized zin Fig. 5. The
0 1 2 3 4
Hours at 40"C before lh at 43C +drug
FIG. 4. The effect on the survival of EMT6
cells of preheat exposures of 0-4 h at 400C
before a lh exposure to 43°C and ADR.
0 Heat alone; A 01 ,ug/ml ADR; * 10
tzg/ml ADR. Error bars represent 2 s.e.
ordinate gives the mean ofthe ratios ofthe
surviving fractions of preheated to non-
preheated cells treated for 1 h at 4300 with
0, 0-33, or 3-3 ,g/ml ADR. This ratio
indicates the amount of induced thermal
tolerance. The abscissa gives the preheat
temperature (for 3 h in all cases). Thermal
tolerance, in the absence of drug, is first
observed at 39T0 and remains fairly con-
stant over the temperature range studied.
However, in the presence of low doses of
ADR (e.g. 0-33 ,ug/ml, shown) the magni-
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FIG. 5.-The effect ofpreheat temperature on
the ratio of cell survival of preheated to
non-preheated EMT6 cells treated for 1 h
at 430C with 0, 0 33 or 3-3 ,ug/ml ADR.
Preheating was for 3 h at all temperatures.
o Preheat+ 1 h at 430C. No drug present;
* Preheat+ 1 h at 430C with 0-33 ug/ml
ADR; Preheat+1 h at 430C with 3-3
,ug/ml ADR.
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FIG. 6. The effect of a 3h pretreatment at
40°C on the subsequent response of EMT6
cells to BCNU (a), and ADR (b) at 37°C for
h. 0 lh at 37°C; A 3 h at 40°C+lhat
37°C. Error bars represent 2 s.e.
tude of thermal tolerance appears to rise
gradually with increasing preheat tem-
perature to the value observed for heat
alone. At a higher dose of ADR (3.3 ttg/
ml) no thermal tolerance develops under
the conditions studied.
Thermal tolerance and drug cytotoxicity
at 370C
Drug cytotoxicity at 370C has been
studied after periods of preheat at either
400C or 43°C. Fig. 6 shows the dose re-
ponse curves at 37°C for BCNU and ADR
with and without preheat treatment of 3 h
at 40°C. The data for these drugs, and also
for BLM (not shown) shows that this pre-
heat treatment has no effect on subsequent
cytotoxicity at 37°C. Further work with
ADR after preheat treatments at 390, 41°
and 420C also showed no effect.
At preheat temperatures above 42 5°C
we observe different effects. Preheating
for 1 h at 43°C sensitizes cells to subse-
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FIG. 7. The effect of a lh pretreatment at
43°C on the subsequent response of EMT6
cells to BLMI (a) and ADR (b) at 37°C for
l h. @ 1 h at 37°C; * 1 h at 43°C±+ h at
37°C (surviving fractions normalized for
killing during 1 h ar 43°C). Error bars
represent 2 s.e.
quent BLM and BCNU toxicity at 37TC
but, in contrast, it protects against subse-
quent ADR toxicity. Dose-response curves
illustrating these effects for BLM and
ADR are shown in Fig. 7. Exposure to
BLM (15 jig/ml) for 1 h at 37TC without
any period ofpreheat reduces cell survival
to 20%. After preheating for 1 h at 43TC,
the cell survival after 1 h at 37°C with
15 Kg/ml BLM is about 300, after normal-
ization for cell killing caused by 1 h at
43°C, compared with about 010% after 1 h
at 43TC with 15 [g/ml BLM. The time
course of recovery from this potentiated
toxicity at 37°C by preheat at 43°C has
been found to follow an exponential
course. All potentiation is eliminated by
12 h at 37°C after the preheat period.
Similarly for ADR, the protective effect
of the preheat period is eliminated after
12 h at 37°C.
DISCUSSION
The initial studies showed that preheat-
ing for a period of several hours at 40°C
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induced a state of tolerance to subsequent
exposures of 1 h at 43°C in our in vitro
EMT6 cell line. This development of
tolerance is in accordance with the find-
ings of Gerner et al. (1976) and Harisiadis
et al. (1977), although the conditions for
its development are different.
Some workers define thermal tolerance
specifically as a reduction in the slope of
the survival curve when cell survival
is plotted against time at any raised tem-
perature (Henle et al., 1 978). However, in
this series of experiments we are con-
sidering any evidence ofprotection against
a subsequent treatment (whether thermal
or otherwise) as heat-induced tolerance.
Using 3 h preheat at 40°C followed by a
I h 43°C heat shock combined with either
BCNU or BLM, tolerance to these drugs
was seen. Donaldson et al. (1978) have
demonstrated with CHO cells the develop-
ment of heat-induced actinomycin D
(AMD) tolerance after a minimum of
30 min heating at 43°C, for 0 5 ,ug/ml
AMD. They found greater protection with
longer heat exposures. Labelled drug
studies excluded the possibilitv of a
heat-induced reduction in intracellular
AMD concentration mediated by mem-
brane-permeability changes. Similarly,
Hahn & Strande (1976) have shown for
CHO cells tolerance to ADR at 43°C
induced by preheat at 43°C for more than
50 min. They suggest that this may be ex-
plained by a reduced intracellular con-
centration of ADR. They show flow-
cytofluorimetric data illustrating that
total cellular fluorescence of 2h preheated
cells is less than that of non-preheated
cells for an unstated ADR concentration.
Similar studies in this laboratory (Cham-
bers, unpublished) have confirmed this
qualitative difference using 30 jug/ml
ADR. However, at the much lower drug
concentrations used in this present work
there were no significant differences be-
tween levels in preheated and non-
preheated cells, within the limits of reso-
lution of the method. Hahn & Strande
(1976) suggest that cell-membrane per-
meability to ADR is iinitially increased
by hyperthermia, but subsequently re-
versed, to exclude ADR from sensitive
sites. However, it is not at all clear that a
change in intracellular ADR concentration
is responsible for the effects seen by Hahn
& Strande and the present authors.
In this report, cells preheated for 3 h at
40°C followed by ADR for 1 h at 43°C
show results which contrast with both our
results for BCNU and BLM and those of
Hahn & Strande for ADR. Fig. 5 shows
that at the higher concentration of ADR
(3.3 jug/ml) there is no heat-induced
tolerance to the combined treatment. At
the lower concentration of 0 33 ,tg/ml, less
thermal tolerance is seen than for heat
alone with preheat temperatures of 39°C
and 40°C, but at preheat temperatures of
41°C and 42°C it appears that the full
thermal tolerance is expressed. There are
two possible interpretations of these data.
Either increasing doses of ADR pro-
gressively reduce heat-induced thermal
tolerance, or the period of preheat poten-
tiates ADR toxicity at 43°C such that it
opposes and, at 3 3 Htg/ml, completely
eliminates heat-induced thermal tolerance.
The data from experiments on cells pre-
heated at 40°C and susbequently treated
with drugs at 37°C indicate that each ofthe
two thermally induced effects requires
continued hyperthermia in order to be
expressed. However, the results of experi-
ments on cells preheated at 43°C and
subsequently treated with drugs at 37°C
show that this type of preheat treatment
substantially influences subsequent drug
response at 37°C. Again, BLM and ADR
show qualitatively different results. The
potentiation of 37°C BLM toxicity to
CHO cells by preheating has already been
reported by Braun & Hahn (1975) under
similar conditions. Preheating at 43°C
prior to ADR treatment at 37°C, in con-
trast causes protection to ADR toxicity.
This effect has also been noted by Li &
Hahn (1978) for CHO cells, but whereas
they saw a progressive increase in pro-
tection with time at 37°C after preheat up
to 7 h, in EMT6 we see maximum protec-
tion immediately after the preheating.
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This is maintained for 8 h, but is virtually
eliminated by 12 h at 37°C after pre-
heating.
Thus, we have demonstrated that pre-
heating cells may affect their subsequent
sensitivity to cytotoxic agents. The pheno-
mena involved are complex and have been
shown to be dependent on the drug used,
its concentration and the temperature of
the preheat exposure. For a particular
drug, the different effects with the different
preheat temperatures may reflect the
results of Henle et al. (1978) which show
that heat induced thermal resistance
differs qualitatively above and below
about 43°C (the inflection point of the
Arrhenius plot for thermal inactivation of
mammalian cells). The mechanisms pro-
ducing heat induced drug tolerance (or
sensitization) remain to be elucidated, but
may involve membrane events. Cellular
heat injury, it has been suggested, results
from changes in the cell membrane
(Bowler et al., 1973) and membrane
fluidity is known to affect permeability
and transport systems in intact myco-
plasma cells (McElhaney et al., 1973).
Alterations in membrane fluidity, causing
disintegration ofthe integrity ofthe mem-
brane, are thought to be involved in the
hyperthermic cell death ofE. coli (Yatvin,
1977). Li & Hahn (1978) have shown that
pretreatment of CHO cells with ethanol,
which is known to modify membrane
fluidity, induced resistance to subsequent
heat or ADR exposures. The pattern of
ethanol-induced tolerance was found to
be very similar to that induced by prior
heat exposure, suggesting that membrane
fluidity may also be involved in heat-
induced tolerance.
It is evident that increased under-
standing of hyperthermic effects on mam-
malian cell membranes is required before
mechanisms for thermal tolerance are
likely to be clearly elucidated. Further
work is required to see whether similar
phenomena occur in vivo and whether
these interactions therefore need to be
considered in the treatment of patients.
Clearly, the differences already demon-
strated between different drugs at varying
concentrations and different temperatures
indicate the uncertainties behind such
therapeutic proposals at present.
We are ver.y grateful to L. S. Freedlmani for the
statistical analysis of ouir (lata.
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